The global mRNA Vaccine Market, valued at US$ 21.7 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of -4.3% from 2023 to 2034, reaching US$ 9.6 billion by 2034. mRNA vaccines, utilizing messenger RNA to instruct cells to produce antigens, gained prominence during the COVID-19 pandemic but now face a decline due to waning demand for COVID vaccines. However... https://www.transparencymarketresearch.com/mrna-vaccine-market.html